Literature DB >> 29302434

Surgical treatment of secondary mitral regurgitation: is repair a reasonable option?

Clarence Pingpoh1, Matthias Siepe1, Wolfgang Bothe1.   

Abstract

BACKGROUND: The optimal approach for treating secondary mitral regurgitation (MR) is debated. Since annuloplasty alone has resulted in 30% or more recurrent MR in the mid-term, recent studies suggest mitral valve replacement. However, subvalvular repair strategies as an adjunct to annuloplasty in order to prevent recurrent MR due to ongoing left ventricle (LV) remodeling are becoming increasingly popular. In this study we present short term results of patients with secondary MR who underwent mitral repair using a novel subvalvular repair approach and address the questions whether mitral repair is a reasonable option in these patients.
METHODS: Ten patients presenting with functional MR underwent ring annuloplasty and a subvalvular approximation of the papillary muscles using a technique where the distance between both papillary muscles was adjusted with a Polytetrafluoroethylene (PTFE) string during the saline test (Ring-Noose-String technique).
RESULTS: Nine of ten patients had none-mild MR while in one patient mild-moderate MR due to ongoing leaflet tethering was diagnosed at discharge. In this patient, insufficient adjustment of the PTFE string is hypothesized as the primary mechanism for suboptimal repair. There were no complications related to the novel surgical technique. No patient died during the follow up period.
CONCLUSIONS: The Ring-Noose-String technique provides acceptable repair results in the short term. A longer follow-up is needed to proof its long-term efficacy. Subvalvular techniques such as this may allow a durable repair in patients with secondary MR.

Entities:  

Keywords:  Functional mitral valve regurgitation; papillary muscle approximation; ring noose string technique

Year:  2017        PMID: 29302434      PMCID: PMC5676110          DOI: 10.21037/jovs.2017.09.09

Source DB:  PubMed          Journal:  J Vis Surg        ISSN: 2221-2965


  8 in total

1.  Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty.

Authors:  Agnieszka Ciarka; Jerry Braun; Victoria Delgado; Michel Versteegh; Eric Boersma; Robert Klautz; Robert Dion; Jeroen J Bax; Nico Van de Veire
Journal:  Am J Cardiol       Date:  2010-08-01       Impact factor: 2.778

2.  Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies.

Authors:  S He; A A Fontaine; E Schwammenthal; A P Yoganathan; R A Levine
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

3.  Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: A quantitative clinical study.

Authors:  S F Yiu; M Enriquez-Sarano; C Tribouilloy; J B Seward; A J Tajik
Journal:  Circulation       Date:  2000-09-19       Impact factor: 29.690

4.  Mitral valve procedure in dilated cardiomyopathy: repair or replacement?

Authors:  A M Calafiore; S Gallina; M Di Mauro; F Gaeta; A L Iacò; S D'Alessandro; V Mazzei; G Di Giammarco
Journal:  Ann Thorac Surg       Date:  2001-04       Impact factor: 4.330

5.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  J Am Coll Cardiol       Date:  2014-03-03       Impact factor: 24.094

6.  Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment.

Authors:  Luc A Piérard; Blase A Carabello
Journal:  Eur Heart J       Date:  2010-12-01       Impact factor: 29.983

7.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.

Authors:  Michael A Acker; Michael K Parides; Louis P Perrault; Alan J Moskowitz; Annetine C Gelijns; Pierre Voisine; Peter K Smith; Judy W Hung; Eugene H Blackstone; John D Puskas; Michael Argenziano; James S Gammie; Michael Mack; Deborah D Ascheim; Emilia Bagiella; Ellen G Moquete; T Bruce Ferguson; Keith A Horvath; Nancy L Geller; Marissa A Miller; Y Joseph Woo; David A D'Alessandro; Gorav Ailawadi; Francois Dagenais; Timothy J Gardner; Patrick T O'Gara; Robert E Michler; Irving L Kron
Journal:  N Engl J Med       Date:  2013-11-18       Impact factor: 91.245

8.  Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation.

Authors:  Daniel Goldstein; Alan J Moskowitz; Annetine C Gelijns; Gorav Ailawadi; Michael K Parides; Louis P Perrault; Judy W Hung; Pierre Voisine; Francois Dagenais; A Marc Gillinov; Vinod Thourani; Michael Argenziano; James S Gammie; Michael Mack; Philippe Demers; Pavan Atluri; Eric A Rose; Karen O'Sullivan; Deborah L Williams; Emilia Bagiella; Robert E Michler; Richard D Weisel; Marissa A Miller; Nancy L Geller; Wendy C Taddei-Peters; Peter K Smith; Ellen Moquete; Jessica R Overbey; Irving L Kron; Patrick T O'Gara; Michael A Acker
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

  8 in total
  2 in total

1.  Biomimetic six-axis robots replicate human cardiac papillary muscle motion: pioneering the next generation of biomechanical heart simulator technology.

Authors:  Annabel M Imbrie-Moore; Matthew H Park; Michael J Paulsen; Mark Sellke; Rohun Kulkami; Hanjay Wang; Yuanjia Zhu; Justin M Farry; Alexandra T Bourdillon; Christine Callinan; Haley J Lucian; Camille E Hironaka; Daniela Deschamps; Y Joseph Woo
Journal:  J R Soc Interface       Date:  2020-12-02       Impact factor: 4.118

Review 2.  Surgical mitral valve repair technique considerations based on the available evidence.

Authors:  Tolga Can; Hristo Kirov; Tulio Caldonazo; Murat Mukharyamov; Gloria Färber; Torsten Doenst
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2022-04-27       Impact factor: 0.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.